Literature DB >> 12044440

Triple valve replacement in a patient with severe carcinoid heart disease.

M Wilhelmi1, M K H Fritz, S Fischer, A Haverich, W Harringer.   

Abstract

We report on the case of a 34-year-old male patient suffering from end-stage carcinoid heart disease with severe tricuspid, pulmonary and mitral valve regurgitation. In addition, a persisting foramen ovale was present. The primary carcinoid tumor was never discovered. However, urine 5-hydroxy-indole-acetic-acid (5-HIAA) were consistently elevated after the first diagnosis of carcinoid disease and after eight years of medication with Octreotide and Interferon alpha-2b our patient developed significant cardiac insufficiency mainly due to severe valvular dysfunction. Ultimately, mechanical tricuspid, mitral and pulmonary valve replacement was performed. Twelve hours following the operation the patient had to be returned to the operating room for persisting intrathoracic hemorrhage. He recovered uneventfully and was discharged from hospital on day 37. Twelve months following triple valve replacement the cardiac status recovered from preoperative NYHA-IV to NYHA-I.

Entities:  

Mesh:

Year:  2002        PMID: 12044440     DOI: 10.1016/s0967-2109(01)00137-5

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  3 in total

1.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

Review 2.  The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment.

Authors:  Dinu Valentin Balanescu; Teodora Donisan; Juan Lopez-Mattei; Saamir Hassan; Peter Kim; Arvind Dasari; Daniel Halperin; James Yao; Biswajit Kar; Igor Gregoric; Serban Mihai Balanescu; Cezar Iliescu
Journal:  Oncol Lett       Date:  2018-11-19       Impact factor: 2.967

3.  Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.

Authors:  J Maroun; W Kocha; L Kvols; G Bjarnason; E Chen; C Germond; S Hanna; P Poitras; D Rayson; R Reid; J Rivera; A Roy; A Shah; L Sideris; L Siu; R Wong
Journal:  Curr Oncol       Date:  2006-04       Impact factor: 3.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.